DR DP SHAH'S PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: F82679 | DAGENHAM, RM10 8EJ
Showing results 301-350 of 428
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 24 | 679 | £64 | +197.8% ▲ | |
| 24 | 7,014 | £430 | -88.9% ▼ | |
| 24 | 1,725 | £608 | -41.4% ▼ | |
| Pancreatin | 23 | 3,000 | £720 | -79.3% ▼ |
| Trimethoprim | 23 | 720 | £51 | -88.7% ▼ |
| Coal tar | 23 | 5,775 | £119 | -68.4% ▼ |
| Nicorandil | 22 | 2,100 | £308 | -84.7% ▼ |
| Midodrine hydrochloride | 22 | 1,232 | £232 | -54.8% ▼ |
| Fluconazole | 22 | 454 | £194 | -71.5% ▼ |
| Baclofen | 22 | 3,764 | £86 | -89.0% ▼ |
| Brimonidine tartrate | 22 | 115 | £58 | -44.9% ▼ |
| 22 | 1,830 | £3.4K | -54.9% ▼ | |
| 22 | 3,750 | £528 | +23.9% ▲ | |
| 22 | 2,030 | £448 | -44.0% ▼ | |
| Colesevelam hydrochloride | 21 | 3,780 | £1.5K | -44.7% ▼ |
| Etoricoxib | 21 | 588 | £142 | -73.9% ▼ |
| Hypromellose | 21 | 240 | £73 | -84.2% ▼ |
| Amorolfine hydrochloride | 21 | 105 | £132 | -9.1% ▼ |
| 21 | 690 | £3.5K | +80.8% ▲ | |
| Indacaterol/glycopyrronium | 20 | 1,020 | £1.1K | -55.7% ▼ |
| Clomipramine hydrochloride | 20 | 336 | £55 | -52.6% ▼ |
| Metoclopramide hydrochloride | 20 | 2,546 | £205 | -75.9% ▼ |
| Erythromycin | 20 | 860 | £219 | -42.3% ▼ |
| Mycophenolate mofetil | 20 | 2,296 | £896 | -50.6% ▼ |
| Oral rehydration salts | 20 | 378 | £159 | -30.8% ▼ |
| Colchicine | 20 | 1,206 | £22 | -74.4% ▼ |
| Adapalene and benzoyl peroxide | 20 | 945 | £412 | -62.6% ▼ |
| 20 | 600 | £2.1K | +157.6% ▲ | |
| Pantoprazole | 19 | 924 | £46 | -93.1% ▼ |
| Valsartan | 18 | 1,148 | £280 | -69.4% ▼ |
| Cinnarizine | 18 | 1,512 | £68 | -61.5% ▼ |
| Tamsulosin and dutasteride hydrochloride | 18 | 780 | £337 | -48.5% ▼ |
| Oxybutynin | 18 | 896 | £21 | -90.6% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 18 | 92.8K | £910 | -3.9% ▼ |
| Tacrolimus | 18 | 1,230 | £935 | -66.6% ▼ |
| Other individually formulated bought in preparations | 18 | 284 | £31 | -44.9% ▼ |
| Sennosides | 17 | 8,500 | £159 | -45.0% ▼ |
| Methyldopa | 17 | 2,064 | £398 | -0.2% vs avg |
| Atomoxetine hydrochloride | 17 | 476 | £1.0K | -49.7% ▼ |
| Isophane insulin | 17 | 90 | £391 | -83.9% ▼ |
| Progesterone | 17 | 448 | £206 | -95.9% ▼ |
| Tamoxifen citrate | 17 | 1,140 | £85 | -79.4% ▼ |
| Magnesium glycerophosphate | 17 | 1,316 | £607 | +23.7% ▲ |
| Heparinoid | 17 | 2,125 | £116 | -35.2% ▼ |
| Neomycin sulfate | 17 | 270 | £34 | -71.3% ▼ |
| 17 | 690 | £80 | -56.9% ▼ | |
| Telmisartan | 16 | 616 | £158 | -72.4% ▼ |
| Dosulepin hydrochloride | 16 | 476 | £92 | -71.7% ▼ |
| Varenicline tartrate | 16 | 531 | £622 | +61.6% ▲ |
| Metformin hydrochloride/sitagliptin | 16 | 1,064 | £333 | -57.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.